Cinemark (CNK) News Today

Cinemark Holdings Inc (NYSE:CNK) is seeing mixed analyst activity today amid industry recovery signals and earnings forecast revisions. Positive momentum from bullish ratings contrasts with downward adjustments to profit estimates, leading to volatility in the stock price.

• Positive Sentiment: Wedbush notes that movie releases are stabilizing as the industry recovers, underlining its bullish stance on Cinemark. Wedbush bullish on AMC and Cinemark as industry recovers, movie releases stabilize
• Positive Sentiment: Wedbush upgraded CNK from “Neutral” to “Outperform” and raised its price target to $37 (from $32), implying roughly 24% upside. Cinemark (NYSE:CNK) Raised to "Outperform" at Wedbush
• Positive Sentiment: Deutsche Bank initiated coverage of Cinemark with a Buy rating and a $36 price objective, highlighting a recovery in the film exhibition sector. Deutsche Bank Aktiengesellschaft Begins Coverage on Cinemark (NYSE:CNK)
• Neutral Sentiment: Despite cutting its earnings forecasts, Roth Capital reaffirmed a Buy rating with a $35 target for CNK, reflecting confidence in longer-term recovery. Roth Capital Lowers Cinemark (NYSE:CNK) Price Target to $35.00
• Negative Sentiment: Roth Capital cut its Q2 EPS estimate for Cinemark to $0.63 from $0.81, signaling a softer near-term earnings outlook. Roth Capital Has Pessimistic Outlook of Cinemark Q2 Earnings
• Negative Sentiment: Analysts at Roth Capital reduced their FY2025 EPS projection to $1.28 (from $1.46), revising down full-year expectations. FY2025 Earnings Forecast for Cinemark Issued By Roth Capital
• Negative Sentiment: Cinemark shares dipped following an analyst price-target downgrade, with the stock falling over 6%. Cinemark (NYSE:CNK) Stock Price Down 6.1% on Analyst Downgrade